Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajesh Agarwal

Showing results (1-10 of 299) with videos related to

Pageof 30
Sort By:
Drug Development Research|November 4, 2009
Natural products and colon cancer: current status and future prospectsSubapriya Rajamanickam, Rajesh Agarwal
Future Oncology (London, England)|May 31, 2013
Promise and potential of silibinin in colorectal cancer management: what patterns can be seen?Komal Raina, Rajesh Agarwal
Cancer Letters|May 13, 2008
Multitargeted therapy of cancer by silymarinKumaraguruparan Ramasamy, Rajesh Agarwal
Current Opinion in Investigational Drugs (London, England : 2000)|June 3, 2008
New combination therapies with cell-cycle agentsGagan Deep, Rajesh Agarwal
Toxicology and Applied Pharmacology|December 23, 2006
Silymarin and epithelial cancer chemoprevention: how close we are to bedside?Manjinder Kaur, Rajesh Agarwal
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Kava, a tonic for relieving the irrational development of natural preventive agentsRajesh Agarwal, Gagan Deep
The Indian Journal of Radiology & Imaging|January 18, 2020
Prenatally diagnosed case of tricuspid valve dysplasia: A case report with review of the literaturePrateek Agarwal, Rajesh Agarwal
Experimental Eye Research|August 12, 2022
Research models of sulfur mustard- and nitrogen mustard-induced ocular injuries and potential therapeuticsNeha Mishra, Rajesh Agarwal
Current Cancer Drug Targets|April 27, 2013
Targeting tumor microenvironment with silibinin: promise and potential for a translational cancer chemopreventive strategyGagan Deep, Rajesh Agarwal
Integrative Cancer Therapies|June 6, 2007
Chemopreventive efficacy of silymarin in skin and prostate cancerGagan Deep, Rajesh Agarwal
Pageof 30

Showing results (1-10 of 299) with videos related to

Sort By:
Pageof 30
Drug Development Research|November 4, 2009
Natural products and colon cancer: current status and future prospectsSubapriya Rajamanickam, Rajesh Agarwal
Future Oncology (London, England)|May 31, 2013
Promise and potential of silibinin in colorectal cancer management: what patterns can be seen?Komal Raina, Rajesh Agarwal
Cancer Letters|May 13, 2008
Multitargeted therapy of cancer by silymarinKumaraguruparan Ramasamy, Rajesh Agarwal
Current Opinion in Investigational Drugs (London, England : 2000)|June 3, 2008
New combination therapies with cell-cycle agentsGagan Deep, Rajesh Agarwal
Toxicology and Applied Pharmacology|December 23, 2006
Silymarin and epithelial cancer chemoprevention: how close we are to bedside?Manjinder Kaur, Rajesh Agarwal
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Kava, a tonic for relieving the irrational development of natural preventive agentsRajesh Agarwal, Gagan Deep
The Indian Journal of Radiology & Imaging|January 18, 2020
Prenatally diagnosed case of tricuspid valve dysplasia: A case report with review of the literaturePrateek Agarwal, Rajesh Agarwal
Experimental Eye Research|August 12, 2022
Research models of sulfur mustard- and nitrogen mustard-induced ocular injuries and potential therapeuticsNeha Mishra, Rajesh Agarwal
Current Cancer Drug Targets|April 27, 2013
Targeting tumor microenvironment with silibinin: promise and potential for a translational cancer chemopreventive strategyGagan Deep, Rajesh Agarwal
Integrative Cancer Therapies|June 6, 2007
Chemopreventive efficacy of silymarin in skin and prostate cancerGagan Deep, Rajesh Agarwal
Pageof 30